Absence of apolipoprotein E4 genotype, good gallbladder motility and presence of solitary stones delay rather than prevent gallstone recurrence afterextracorporeal shock wave lithotripsy
Ng. Venneman et al., Absence of apolipoprotein E4 genotype, good gallbladder motility and presence of solitary stones delay rather than prevent gallstone recurrence afterextracorporeal shock wave lithotripsy, J HEPATOL, 35(1), 2001, pp. 10-16
Background/Aims: Extracorporeal shock wave lithotripsy (ESWL) with adjuvant
bile salt dissolution therapy may be successful in selected gallstone pati
ents, but the considerable risk of recurrence is a major drawback. Apolipop
rotein E4 genotype and impaired gallbladder motility have been identified a
s major risk factors for recurrence during shortterm follow up. We have now
examined their relevance during long-term follow up.
Methods: Eighty-four cholesterol gallstone patients (55 solitary and 29 mul
tiple (two to ten) stones) were followed prospectively up to 10 years after
complete stone disappearance. Various potential risk factors for recurrenc
e were evaluated.
Results: Gallstone recurrence was found in up to 80 % of patients at 10 yea
rs follow-up. Absence of the apolipoprotein epsilon4 allele, initial solita
ry stones, good gallbladder emptying (i.e. minimal postprandial volume less
than or equal to6 ml) and 2-year postdissolution ursodeoxycholic acid prop
hylaxis tin ten patients) all delayed but did not prevent recurrence. In co
ntrast, regular use of non-steroidal anti-inflammatory drugs (NSAIDs) was i
dentified as an independent protective factor, with greatly decreased recur
rence (at 10 years: 58 vs 93% in non-NSAID users, P = 0.03).
Conclusions: Non-apolipoprotein E4 genotype, presence of Solitary stones an
d good gallbladder emptying delay rather than prevent recurrence after init
ially successful ESWL. Regular use of NSAIDs may prevent recurrence. (C) 20
01 European Association for the Study of the Liver. Published by Elsevier S
cience B.V. All rights reserved.